
Janus Henderson Global Life Sciences Fund
JFNAX
Updated: 04/11/2026, 12:56:03
No historical data available
The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.
No summaries found.
- Share price
- $90.20
- Market cap
- $5.80B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 06/07/2009
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $90.09 – $90.20
- 52-week range
- $73.42 – $91.65
- 1-day performance
- 0.12%
- 1-year performance
- 22.85%
- Current drawdown (1Y)
- -1.58%
- CIK
- 0000277751
- CUSIP
- 471023481
- ISIN
- US4710234810
- Created
- 07/12/2025, 04:50:56
- Last update
- 04/11/2026, 12:56:03
Track Janus Henderson Global Life Sciences Fund with an AI analyst
See which prediction-market events move JFNAX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.